Asia · News · The Asahi Shimbun
First heart patch transplant moves iPS therapy from lab to clinic
OSAKA—A regenerative medical product derived from induced pluripotent stem (iPS) cells was used to treat a patient in a clinical setting here for the first time in the world.
Read the full article on The Asahi Shimbun Sign in to saveMediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.asahi.com)




